台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    27.85
  • 漲跌
    ▲0.35
  • 漲幅
    +1.27%
  • 成交量
    725
  • 產業
    上市 生技醫療類股
  • 301人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
神隆 (1789)籌碼相關-富邦-忠孝 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-忠孝 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/12/080.126.65226.5026.35-1.9787-0.24%
2023/12/04227.5000.0027.2027760.26%
2023/11/0800.00426.3526.05-4794-0.50%
2023/11/07428.0000.0027.4547640.52%
2023/09/2000.00127.3027.25-12,741-0.04%
2023/09/1900.00227.6527.70-22,763-0.07%
2023/09/1200.00326.9526.80-32,968-0.10%
2023/09/0500.00527.3027.25-53,085-0.16%
2023/08/1400.00227.8828.00-23,066-0.07%
2023/08/1100.00128.6528.55-13,053-0.03%
2023/08/1000.00428.9529.05-43,039-0.13%
2023/08/0900.00130.7530.75-12,987-0.03%
2023/08/08330.8500.0030.9032,9850.10%
2023/07/3100.00132.0031.85-12,875-0.03%
2023/07/25332.25332.9332.8002,8500.00%
2023/07/2400.00332.3032.10-32,862-0.10%
2023/07/21132.0000.0031.5012,8010.04%
2023/07/20932.44530.7031.3042,6860.15%
2023/07/19233.155.134.4733.35-3.12,390-0.13%
2023/07/18533.874.134.5833.700.92,2130.04%
2023/07/170.132.75332.9033.25-2.91,891-0.15%
2023/07/14530.1000.0030.2551,8060.28%
2023/07/1200.00629.0028.95-61,820-0.33%
2023/07/107.129.6100.0029.507.11,8490.38%
2023/07/0400.00230.1829.75-21,727-0.12%
2023/06/30230.1500.0030.2521,6550.12%
2023/06/28329.3000.0029.4031,5380.19%
2023/06/2600.00328.9028.75-31,481-0.20%
2023/06/2100.00229.0028.95-21,476-0.14%
2023/06/1900.00128.9529.00-11,410-0.07%
2023/06/16328.8200.0028.6031,3560.22%
2023/06/1500.002028.0928.05-201,274-1.57%
2023/06/1300.00127.3027.70-11,214-0.08%
2023/06/1200.00227.0326.90-21,177-0.17%
2023/06/081926.6200.0026.35191,1621.63%
2023/06/07326.7500.0026.9031,1640.26%
2023/05/2400.000.126.8026.60-0.11,208-0.01%
2023/05/2200.00126.6526.55-11,215-0.08%
2023/05/05228.2000.0028.1521,1640.17%
2023/05/0200.00128.3528.65-11,171-0.09%
2023/04/28128.9000.0028.4011,1540.09%
2023/04/1400.00127.1527.00-1931-0.11%
2023/04/1300.001626.3826.35-16884-1.81%
2023/04/11126.2000.0026.2019190.11%
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章